Skip to content

Screening and verification of metabolic biomarkers in peripheral blood of patients with femoral head necrosis

Screening and verification of metabolic biomarkers in peripheral blood of patients with femoral head necrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033442
Enrollment
Unknown
Registered
2020-06-01
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

femoral head necrosis

Interventions

Gold Standard:Clinical features and image data
of&#32
by&#32

Sponsors

Honghui Hospital, Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Have received or are receiving corticosteroid treatment; 2. Drinking history of more than 5 years; 3. Progressive hip pain, worsening when standing or walking or accompanied by limited hip movement; 4. Imaging examination: X film The display and CT showed extensive osteoporosis with osteosclerosis or cystic changes, or femoral head collapse, crescent sign, and normal or narrow joint space. MRI examination shows that the T1-weighted femoral head weight-bearing area shows a line-like low signal, or a crescent-shaped uneven signal or band-shaped low signal with a clear boundary; T2 weighted shows a high signal, or a double line formed with a slightly lower signal surrounding the uneven Sign, or collapse and deformation of the femoral head, acetabular sclerosis, cystic changes, and marginal osteophyte. Diagnostic criteria: meet with item 1, 3, and 4 is hormonal femoral head necrosis; meet item 2, 3, and 4 is alcoholic femoral head necrosis.

Exclusion criteria

Exclusion criteria: The case group: History of femoral neck fracture or hip dislocation before onset; history of seronegative arthritis such as rheumatism, rheumatoid arthritis, and osteoarthritis; persons engaged in diving and aviation; and obvious familial genetic diseases. The control group: Select healthy medical personnel whose age, gender, race, and place of residence matched the cases; those with no history of hip pain and joint dysfunction.

Design outcomes

Primary

MeasureTime frame
plasma metabolome;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactHeping Zhao

Honghui Hospital, Xi'an Jiaotong University

redcrossjyk@163.com+86 13991394223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026